REFERENCES
- Ohlsson K. Properties of leucocytic protease. Clin Chim Acta 1971; 32: 399–405.
- Ohlsson K, Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases. Eur J Biochem 1973; 36: 473–81.
- Ohlsson K. In: Wooley DE, Evanson JM, eds. Normal and pathological connective tissues. John Wiley & Sons Ltd, 1980; 209–22.
- Ohlsson K, Linder C, Rosengren M. Monoclonal antibodies specific for neutrophil proteinase. 4. Production and use for isolation of the enzyme. Hoppe-Seyler J Biol Chem 1990: 371.
- Thompson RC, Ohlsson K. Isotation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci, USA, 1986; 83: 6692–6.
- Hewick RM, Hunkapiller MW, Hood LE, Dreyer WJ. A gas-liquid solid phase peptide and protein sequencer. J Biol Chem 1981; 256: 7990–7.
- Thorell J, Johansson BG. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim Biophys Acta 1971; 251: 363–7.
- Visser L, Blout ER. Elastase substrates and inhibitors. Fed Proc 1969; 28: 407–14.
- Laurell CB. Electroimmunoassay. Scand J Clin Lab Invest 1972; 29(Suppl. 124): 21–37.
- Ganrot PO. Crossed immunoelectrophoresis. Scand J Clin Lab Invest 1972; 29(Suppl. 124): 39–47.
- Ohlsson K, Olsson AS. Immunoreactive granulocyte elastase in human serum. Hoppe-Seyler's Z Physiol Chem 1978; 359: 1531–9.
- Plow EF. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. J Clin Invest 1982; 69: 564–73.
- Axelsson L, Bergenfeldt M, Björk P. Olsson R, Ohlsson K. Release of immunoreactive canine leucocyte elastase, normally and in endotoxin and pancreatic shock. Scand J Clin Lab Invest 1990; 50: 35–42.
- Ohlsson K, Olsson I. Neutral proteases of human granulocytes. III. Interaction between human granulocyte elastase and plasma protease inhibitors. Scand J Clin Lab Invest 1974; 34: 3493–55.
- Ohlsson K, Åkesson U. Alphal-antichymotrypsin interaction with cationic proteins from granulocytes. Clin Chim Acta 1976; 73: 285–91.
- Neumann S, Hennrich N, Gunzer G, Lang H. Enzyme-linked immunoassay for human granulocyte elastase in complex with alphal-proteinase inhibitor. In: Hörl WH, Heidlund A, eds. Proteases, Potential Role in Health and Disease. New York: Plenum Press, 1984; 379–90.
- Seiz R, Wolf M, Egbring R, Radtke KP, Ziesen-feld A, Pittner P, Havemann K. Participation and interactions of neutrophil elastase in haemostatic disorders of patients with severe infections. Blood 1987; 120: 544–55.
- Fritz H. In: Evered D, Whelen J, eds. Ciba Foundation Symposium, Vol. 75. Excerpta Medica, Amsterdam, 1980; 75: 351–75.
- Sinha S, Watorek W, Karr S, Giles J, Bode W, Travis J. Primary structure of human neutrophil elastase. Proc Natl Acad Sci, USA 1987; 84: 2228–32.
- Salvesen G, Farley D, Schuman J, Przybyla A, Reilly C, Travis J. Molecular cloning of human cathepsin G: structural similarity to mast ell and cytotoxic T lymphocyte proteinases. Biochemistry 1987; 26: 2289–93.
- Jenne DE, Tschopp J, Ludemann J, Utecht B, Gross WL. Wegeners's autoantigen decoded. Nature 1990; 346: 520.